NOVARTIS AG (NVSEF)
Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30
Clinical trial NCT07549139 updates: 1. start date: 2026-06-30 → 2026-10-31 2. completion date: 2027-12-31 → 2028-04-30 3. primary completion date: 2027-12-31 → 2028-04-30
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical